Table 2.
Group | Output power |
LED illumination time (min) | TBO incubation time (min) | inactivation |
---|---|---|---|---|
(mW) | effect (%) | |||
Negative control | 0 | 0 | 0 | 1.43 ± 0.67 |
aPDT | 500 | 1 | 1 | 92.41 ± 3.84a |
5 | 92.93 ± 3.61a | |||
10 | 92.97 ± 3.87a | |||
2 | 1 | 99.82 ± 0.29a | ||
5 | 99.95 ± 0.07a | |||
10 | 99.54 ± 0.64a | |||
750 | 1 | 1 | 99.75 ± 0.20a | |
5 | 99.92 ± 0.09a | |||
10 | 99.83 ± 0.25a | |||
2 | 1 | 99.74 ± 0.23a | ||
5 | 99.63 ± 0.30a | |||
10 | 99.86 ± 0.14a | |||
P value | <0.01 |
TBO, toluidine blue O; aPDT, antimicrobial photodynamic therapy; LED, light-emitting diode; a, P < 0.05 vs. negative control.